Alnylam Pharmaceuticals (ALNY) PT Raised to $115 at BofA/Merrill Lynch
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $224.60 -1.77%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
BofA/Merrill Lynch analyst Tazeen Ahmad raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $115.00 (from $110.00) while maintaining a Buy rating.
You May Also Be Interested In
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $256 at Wells Fargo
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
